Parkinson's Disease News

The test was developed by Dr. Mark Gluck, professor of neuroscience at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark, working with co-researchers at Rutgers, New York University, and in Hungary.

Addex Achieves Second Milestone in Parkinson's Disease Collaboration with Merck & Co., Inc.

A damning report has highlighted severe inequalities in access to Parkinson's services across the UK.

Thursday, 9 July 2009, 3:00 pm Press Release: Neurological Foundation The Neurological Foundation of New Zealand awarded more than $800,000 in research grants, travel grants and scholarships for its July 2009 funding round, announced on Friday, July 3. A further $300,000 was awarded under the University of Auckland, Centre for Brain Research ...

Patients with Parkinson's disease are suffering delays in diagnosis and being deprived of specialist treatment because of "appalling gaps" in NHS care, a report by MPs and peers says today.

Main Category: Parkinson's Disease Also Included In: Infectious Diseases / Bacteria / Viruses Article Date: 06 Jul 2009 Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extreme drug-resistant tuberculosis, which kills about 2 million people each year, according to a study led by ...

Parkison's Disease Drugs Could Treat MDR-TB, XDR-TB Researchers said "computer models and lab experiments suggest the drugs tolcapone or Tasmar made by Valeant Pharmaceuticals, and entacapone or Comtan made by Novartis AG [used to treat Parkinson's disease] have the potential to treat" multi-drug resistant tuberculosis and extensively ...

Extreme drug-resistant tuberculosis kills about two million people each year; a number researchers are trying to lower with new medicines for TB.

Q: Please explain progressive supranuclear palsy. Is it hereditary? What causes it, and what are its symptoms? Can anything be done to prevent it? A: Progressive supranuclear palsy stems from deterioration of brain cells in specific areas.

Bradley University is getting nearly $10,000 for research on neurodegenerative diseases.

Michel Medina Gonzalez shook violently in his chair inside a patient room at Orlando Health, where he was fitted earlier this month with a brain implant to control his symptoms of Parkinson's disease.

Washington, July 3: Two drugs that are commonly used to treat Parkinson's disease have been found to be effective in treating extreme drug-resistant tuberculosis, say researchers at the University of California, San Diego.

DEAR DR. DONOHUE: I have read different articles on the benefits of coenzyme Q10.

Santhera Pharmaceuticals , a Swiss specialty pharmaceutical company focused on neuromuscular diseases, announced today positive data from its Phase IIb study .

Main Category: Stem Cell Research Also Included In: Neurology / Neuroscience ; Alzheimer's / Dementia ; Parkinson's Disease Article Date: 01 Jul 2009 - 5:00 PDT Neural stem cells represent the cellular backup of our brain.

A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make.

BOB ROHRMAN has never had much time for computer games. He was given a console a year ago, but stopped using it after a few weeks.

UCB announced that Neupro can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.

Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending the approval of a once daily formulation for Mirapexin/ Sifrol , in all countries of the European Union, Norway, Iceland and Liechtenstein.

Dear Dr. Gott: I injured my back in a fall on ice six years ago. I had surgery on my back in 2007, with three spacers inserted.